Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$696.4K
4 trades · 1 insiders
Net · 90d
$-696.4K
Insiders on file
28
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Tousignant Jennifer | Chief Legal Officer | 18 | $0 | $767.2K | 2026-08-19 |
| Tripuraneni Radhika | Chief Medical Officer | 7 | $0 | $0 | 2026-08-14 |
| Gheuens Sarah | Director | 4 | $0 | $0 | 2026-07-01 |
| Kiselak Tomas | Director | 7 | $0 | $0 | 2026-07-01 |
| CAIN CHRISTOPHER W. | Director | 3 | $0 | $0 | 2026-07-01 |
| Moses Jennifer K. | Director | 6 | $0 | $0 | 2026-07-01 |
| Ajer Jeffrey Robert | Director | 3 | $0 | $0 | 2026-07-01 |
| Morris Arlene | Director | 7 | $0 | $0 | 2026-07-01 |
| Fairmount Healthcare Fund II L.P. | Director, 10% Owner | 7 | $60.00M | $0 | 2026-05-11 |
| Harmon Seth | See Remarks | 9 | $0 | $0 | 2026-03-03 |
| Mahoney Stephen F. | President and CEO | 10 | $499.3K | $0 | 2026-03-03 |
| Beetham Thomas W. | Chief Operating Officer | 10 | $117.0K | $0 | 2026-03-03 |
| Fairmount Healthcare Fund II GP LLC | Director, 10% Owner | 1 | $10.00M | $0 | 2025-10-23 |
| Fairmount Funds Management LLC | Director, 10% Owner | 4 | $0 | $0 | 2025-06-10 |
| Harwin Peter Evan | Director | 5 | $0 | $0 | 2024-06-26 |
| Ciulla Thomas | Chief Medical Officer | 1 | $0 | $0 | 2024-02-05 |
| Fairmount Healthcare Fund GP LLC | Director, 10% Owner | 2 | $10.00M | $0 | 2023-10-30 |
| Meisner Lara | General Counsel and Secretary | 44 | $0 | $2.54M | 2023-06-16 |
| Myers Scott Dunseth | Chief Executive Officer | 4 | $261.8K | $0 | 2023-04-12 |
| Melvin Carrie | COO | 1 | $0 | $0 | 2023-02-08 |
| Humer Kristian | CFO and CBO | 4 | $0 | $0 | 2023-02-08 |
| Katz Barrett | Chief Medical Officer | 15 | $0 | $3.17M | 2023-02-08 |
| Violin Jonathan | See Remarks | 17 | $0 | $6.11M | 2023-02-02 |
| Frazier Life Sciences Public Fund, L.P. | 10% Owner | 1 | $2.20M | $0 | 2021-09-23 |
| Fairmount Healthcare Fund L.P. | Director | 1 | $10.00M | $0 | 2021-09-21 |
| Hatfield Jeffrey S. | Director | 1 | $0 | $0 | 2021-02-04 |
| TURNER JOSEPH L | Director | 1 | $0 | $0 | 2021-02-04 |
| Leverone Jason A. | Chief Financial Officer | 1 | $0 | $0 | 2021-01-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Tousignant Jennifer | Chief Legal Officer | M Exercise deriv | 2026-08-19 | 2026-08-20 | 10,000 | — | $0 | 114,072 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | S Sale | 2026-08-19 | 2026-08-20 | 4,212 | $24.50 | $103.2K | 0 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | M Exercise | 2026-08-19 | 2026-08-20 | 10,000 | $14.41 | $144.1K | 10,000 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | S Sale | 2026-08-19 | 2026-08-20 | 10,000 | $24.50 | $245.0K | 0 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | M Exercise deriv | 2026-08-19 | 2026-08-20 | 10,000 | — | $0 | 114,072 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | S Sale | 2026-08-19 | 2026-08-20 | 10,000 | $24.50 | $245.0K | 0 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | M Exercise | 2026-08-19 | 2026-08-20 | 10,000 | $14.41 | $144.1K | 10,000 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | S Sale | 2026-08-19 | 2026-08-20 | 4,212 | $24.50 | $103.2K | 0 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | M Exercise deriv | 2026-08-14 | 2026-08-18 | 40,000 | — | $0 | 0 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | M Exercise | 2026-08-14 | 2026-08-18 | 40,000 | $13.21 | $528.4K | 40,000 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | M Exercise deriv | 2026-08-14 | 2026-08-18 | 40,000 | — | $0 | 0 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | M Exercise | 2026-08-14 | 2026-08-18 | 40,000 | $13.21 | $528.4K | 40,000 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| Gheuens Sarah | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| Moses Jennifer K. | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| Ajer Jeffrey Robert | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| CAIN CHRISTOPHER W. | Director | A Award deriv | 2026-07-01 | 2026-07-02 | 32,341 | — | $0 | 32,341 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | P Buy | 2026-05-11 | 2026-05-13 | 1,176,470 | $17.00 | $20.00M | 5,090,928 | SEC↗ |
| Mahoney Stephen F. | President and CEO | M Exercise deriv | 2026-03-03 | 2026-03-04 | 18,357 | — | $0 | 55,071 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | M Exercise deriv | 2026-03-03 | 2026-03-04 | 9,409 | — | $0 | 28,227 | SEC↗ |
| Harmon Seth | Chief Financial Officer | M Exercise deriv | 2026-03-03 | 2026-03-04 | 6,267 | — | $0 | 18,801 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | M Exercise deriv | 2026-03-03 | 2026-03-04 | 5,169 | — | $0 | 15,510 | SEC↗ |
| Mahoney Stephen F. | President and CEO | M Exercise | 2026-03-03 | 2026-03-04 | 18,357 | — | $0 | 40,757 | SEC↗ |
| Mahoney Stephen F. | President and CEO | F Tax w/h | 2026-03-03 | 2026-03-04 | 7,627 | $29.32 | $223.6K | 33,130 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | F Tax w/h | 2026-03-03 | 2026-03-04 | 3,138 | $29.32 | $92.0K | 13,271 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | M Exercise | 2026-03-03 | 2026-03-04 | 9,409 | — | $0 | 16,409 | SEC↗ |
| Harmon Seth | Chief Financial Officer | F Tax w/h | 2026-03-03 | 2026-03-04 | 2,091 | $29.32 | $61.3K | 7,790 | SEC↗ |
| Harmon Seth | Chief Financial Officer | M Exercise | 2026-03-03 | 2026-03-04 | 6,267 | — | $0 | 9,881 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | F Tax w/h | 2026-03-03 | 2026-03-04 | 1,724 | $29.32 | $50.5K | 3,445 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | M Exercise | 2026-03-03 | 2026-03-04 | 5,169 | — | $0 | 5,169 | SEC↗ |
| Mahoney Stephen F. | President and CEO | F Tax w/h | 2026-03-03 | 2026-03-09 | 7,408 | $30.19 | $223.6K | 33,349 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | F Tax w/h | 2026-03-03 | 2026-03-09 | 1,675 | $30.19 | $50.6K | 3,494 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | F Tax w/h | 2026-03-03 | 2026-03-09 | 3,048 | $30.19 | $92.0K | 13,361 | SEC↗ |
| Harmon Seth | Chief Financial Officer | F Tax w/h | 2026-03-03 | 2026-03-09 | 2,031 | $30.19 | $61.3K | 7,850 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 19,150 | — | $0 | 19,150 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 95,800 | — | $0 | 95,800 | SEC↗ |
| Mahoney Stephen F. | President and CEO | A Award deriv | 2026-03-02 | 2026-03-04 | 559,600 | — | $0 | 559,600 | SEC↗ |
| Mahoney Stephen F. | President and CEO | A Award deriv | 2026-03-02 | 2026-03-04 | 111,900 | — | $0 | 111,900 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 176,550 | — | $0 | 176,550 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 35,300 | — | $0 | 35,300 | SEC↗ |
| Harmon Seth | Chief Financial Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 20,550 | — | $0 | 20,550 | SEC↗ |
| Harmon Seth | Chief Financial Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 102,850 | — | $0 | 102,850 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 23,850 | — | $0 | 23,850 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | A Award deriv | 2026-03-02 | 2026-03-04 | 119,300 | — | $0 | 119,300 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | S Sale | 2025-12-31 | 2026-01-02 | 2,272 | $31.16 | $70.8K | 0 | SEC↗ |
| Fairmount Healthcare Fund II G | Director, 10% Owner | P Buy | 2025-10-23 | 2025-10-27 | 454,545 | $22.00 | $10.00M | 3,914,458 | SEC↗ |
| Moses Jennifer K. | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Gheuens Sarah | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Ajer Jeffrey Robert | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| CAIN CHRISTOPHER W. | Director | A Award deriv | 2025-07-01 | 2025-07-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Fairmount Funds Management LLC | Director, 10% Owner | M Exercise deriv | 2025-06-10 | 2025-06-11 | 12,500 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director, 10% Owner | M Exercise | 2025-06-10 | 2025-06-11 | 12,500 | $12.31 | $153.9K | 3,459,913 | SEC↗ |
| Fairmount Funds Management LLC | Director, 10% Owner | M Exercise deriv | 2025-06-09 | 2025-06-11 | 1,600 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director, 10% Owner | M Exercise | 2025-06-09 | 2025-06-11 | 1,600 | $7.80 | $12.5K | 3,447,413 | SEC↗ |
| Ajer Jeffrey Robert | Director | A Award deriv | 2025-04-07 | 2025-04-09 | 42,000 | — | $0 | 42,000 | SEC↗ |
| CAIN CHRISTOPHER W. | Director | A Award deriv | 2025-03-10 | 2025-03-12 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Tripuraneni Radhika | Chief Medical Officer | A Award deriv | 2025-03-10 | 2025-03-12 | 310,700 | — | $0 | 310,700 | SEC↗ |
| Harmon Seth | Chief Financial Officer | A Award deriv | 2025-03-03 | 2025-03-04 | 25,068 | — | $0 | 25,068 | SEC↗ |
| Harmon Seth | Chief Financial Officer | A Award deriv | 2025-03-03 | 2025-03-04 | 150,407 | — | $0 | 150,407 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | A Award deriv | 2025-03-03 | 2025-03-04 | 37,636 | — | $0 | 37,636 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | A Award deriv | 2025-03-03 | 2025-03-04 | 225,814 | — | $0 | 225,814 | SEC↗ |
| Mahoney Stephen F. | President and CEO | A Award deriv | 2025-03-03 | 2025-03-04 | 440,565 | — | $0 | 440,565 | SEC↗ |
| Mahoney Stephen F. | President and CEO | A Award deriv | 2025-03-03 | 2025-03-04 | 73,428 | — | $0 | 73,428 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | A Award deriv | 2025-03-03 | 2025-03-04 | 124,072 | — | $0 | 124,072 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | A Award deriv | 2025-03-03 | 2025-03-04 | 20,679 | — | $0 | 20,679 | SEC↗ |
| Mahoney Stephen F. | President and CEO | P Buy | 2024-09-27 | 2024-09-30 | 21,400 | $23.33 | $499.3K | 21,400 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | P Buy | 2024-09-27 | 2024-09-30 | 5,000 | $23.41 | $117.0K | 6,000 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | P Buy | 2024-09-13 | 2024-09-17 | 1,600,000 | $18.75 | $30.00M | 3,445,813 | SEC↗ |
| Moses Jennifer K. | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Gheuens Sarah | Director | A Award deriv | 2024-06-26 | 2024-06-28 | 21,000 | — | $0 | 21,000 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | J Other deriv | 2024-03-28 | 2024-04-01 | 21,999 | — | $0 | 0 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | J Other deriv | 2024-03-28 | 2024-04-01 | 21,999 | — | $0 | 133,191 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | J Other | 2024-03-28 | 2024-04-01 | 5,859 | — | $0 | 1,845,813 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | J Other | 2024-03-28 | 2024-04-01 | 5,859 | — | $0 | 0 | SEC↗ |
| Tousignant Jennifer | Chief Legal Officer | A Award deriv | 2024-02-12 | 2024-02-14 | 290,000 | — | $0 | 290,000 | SEC↗ |
| Ciulla Thomas | Chief Medical Officer | A Award deriv | 2024-02-05 | 2024-02-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Fairmount Healthcare Fund II L | Director, 10% Owner | P Buy | 2024-01-22 | 2024-01-24 | 476,190 | $21.00 | $10.00M | 1,839,954 | SEC↗ |
| Harmon Seth | See Remarks | A Award deriv | 2023-11-10 | 2023-11-13 | 270,000 | — | $0 | 270,000 | SEC↗ |
| Mahoney Stephen F. | President and CEO | A Award deriv | 2023-10-30 | 2023-11-01 | 1,259,400 | — | $0 | 1,259,400 | SEC↗ |
| Beetham Thomas W. | Chief Operating Officer | A Award deriv | 2023-10-30 | 2023-11-01 | 474,400 | — | $0 | 474,400 | SEC↗ |
| Fairmount Healthcare Fund GP L | Director | A Award deriv | 2023-10-30 | 2023-11-01 | 48,463 | $825.37 | $40.00M | 48,463 | SEC↗ |
| Gheuens Sarah | Director | A Award deriv | 2023-09-21 | 2023-09-25 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2023-06-16 | 2023-06-20 | 28 | — | $0 | 37,453 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2023-06-16 | 2023-06-20 | 27 | $23.03 | $622 | 29,998 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2023-06-16 | 2023-06-20 | 27 | $28.35 | $765 | 29,971 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2023-06-15 | 2023-06-20 | 2,269 | — | $0 | 37,481 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2023-06-15 | 2023-06-20 | 2,269 | $23.03 | $52.3K | 32,240 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2023-06-15 | 2023-06-20 | 2,269 | $28.02 | $63.6K | 29,971 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Moses Jennifer K. | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2023-06-14 | 2023-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2023-06-06 | 2023-06-06 | 5,126 | — | $0 | 84,375 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2023-06-06 | 2023-06-06 | 5,126 | $18.51 | $94.9K | 35,097 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2023-06-06 | 2023-06-06 | 5,126 | $25.02 | $128.3K | 29,971 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2023-06-05 | 2023-06-06 | 499 | — | $0 | 89,501 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2023-06-05 | 2023-06-06 | 499 | $18.51 | $9.2K | 30,470 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2023-06-05 | 2023-06-06 | 499 | $25.03 | $12.5K | 29,971 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise deriv | 2023-06-02 | 2023-06-06 | 1,875 | — | $0 | 18,128 | SEC↗ |
| Meisner Lara | Chief Legal Officer | S Sale | 2023-06-02 | 2023-06-06 | 1,875 | $24.21 | $45.4K | 29,971 | SEC↗ |
| Meisner Lara | Chief Legal Officer | M Exercise | 2023-06-02 | 2023-06-06 | 1,875 | $14.00 | $26.3K | 31,846 | SEC↗ |
| Myers Scott Dunseth | Chief Executive Officer | P Buy | 2023-04-12 | 2023-04-12 | 4,000 | $25.37 | $101.5K | 259,500 | SEC↗ |
| Myers Scott Dunseth | Chief Executive Officer | P Buy | 2023-03-13 | 2023-03-13 | 5,500 | $29.15 | $160.3K | 255,500 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2023-03-09 | 2023-03-10 | 29,971 | $29.07 | $871.3K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | A Award deriv | 2023-02-08 | 2023-02-10 | 108,000 | — | $0 | 108,000 | SEC↗ |
| Humer Kristian | CFO and CBO | A Award deriv | 2023-02-08 | 2023-02-10 | 108,000 | — | $0 | 108,000 | SEC↗ |
| Melvin Carrie | COO | A Award deriv | 2023-02-08 | 2023-02-10 | 54,000 | — | $0 | 54,000 | SEC↗ |
| Katz Barrett | Chief Medical Officer | A Award deriv | 2023-02-08 | 2023-02-10 | 108,000 | — | $0 | 108,000 | SEC↗ |
| Myers Scott Dunseth | Chief Executive Officer | A Award deriv | 2023-02-06 | 2023-02-07 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Myers Scott Dunseth | Chief Executive Officer | A Award | 2023-02-06 | 2023-02-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | M Exercise deriv | 2023-02-02 | 2023-02-07 | 50,000 | — | $0 | 239,205 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2023-02-02 | 2023-02-03 | 50,000 | $36.80 | $1.84M | 430,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | M Exercise | 2023-02-02 | 2023-02-07 | 50,000 | $0.15 | $7.5K | 530,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2023-02-02 | 2023-02-07 | 50,000 | $36.80 | $1.84M | 480,905 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2023-01-23 | 2023-01-25 | 4,971 | — | $0 | 39,750 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2023-01-23 | 2023-01-25 | 1,872 | — | $0 | 20,003 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2023-01-23 | 2023-01-25 | 1,872 | $14.00 | $26.2K | 6,843 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2023-01-23 | 2023-01-25 | 6,843 | $35.66 | $244.0K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2023-01-23 | 2023-01-25 | 4,971 | $23.03 | $114.5K | 4,971 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise deriv | 2023-01-17 | 2023-01-18 | 24,853 | — | $0 | 267,000 | SEC↗ |
| Katz Barrett | Chief Medical Officer | S Sale | 2023-01-17 | 2023-01-18 | 24,853 | $37.21 | $924.8K | 0 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise | 2023-01-17 | 2023-01-18 | 24,853 | $23.03 | $572.4K | 24,853 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise deriv | 2023-01-13 | 2023-01-18 | 4,147 | — | $0 | 291,853 | SEC↗ |
| Katz Barrett | Chief Medical Officer | S Sale | 2023-01-13 | 2023-01-18 | 4,147 | $37.01 | $153.5K | 0 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise | 2023-01-13 | 2023-01-18 | 4,147 | $23.03 | $95.5K | 4,147 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise deriv | 2023-01-10 | 2023-01-11 | 47,377 | — | $0 | 296,000 | SEC↗ |
| Katz Barrett | Chief Medical Officer | S Sale | 2023-01-10 | 2023-01-11 | 47,377 | $35.30 | $1.67M | 0 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise | 2023-01-10 | 2023-01-11 | 47,377 | $23.03 | $1.09M | 47,377 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise deriv | 2023-01-09 | 2023-01-11 | 12,623 | — | $0 | 343,377 | SEC↗ |
| Katz Barrett | Chief Medical Officer | S Sale | 2023-01-09 | 2023-01-11 | 12,623 | $33.04 | $417.1K | 0 | SEC↗ |
| Katz Barrett | Chief Medical Officer | M Exercise | 2023-01-09 | 2023-01-11 | 12,623 | $23.03 | $290.7K | 12,623 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-12-21 | 2022-12-22 | 16,326 | — | $0 | 44,721 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-12-21 | 2022-12-22 | 16,326 | $29.19 | $476.6K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-12-21 | 2022-12-22 | 16,326 | $23.03 | $376.0K | 16,326 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-12-20 | 2022-12-22 | 600 | — | $0 | 61,047 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-12-20 | 2022-12-22 | 600 | $28.07 | $16.8K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-12-20 | 2022-12-22 | 600 | $23.03 | $13.8K | 600 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-12-16 | 2022-12-19 | 1,297 | — | $0 | 61,647 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-12-16 | 2022-12-19 | 1,297 | $28.44 | $36.9K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-12-16 | 2022-12-19 | 1,297 | $23.03 | $29.9K | 1,297 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-12-15 | 2022-12-19 | 300 | — | $0 | 62,944 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-12-15 | 2022-12-19 | 300 | $28.08 | $8.4K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-12-15 | 2022-12-19 | 300 | $23.03 | $6.9K | 300 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-12-14 | 2022-12-14 | 15,656 | — | $0 | 63,244 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-12-14 | 2022-12-14 | 15,656 | $28.12 | $440.2K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-12-14 | 2022-12-14 | 15,656 | $23.03 | $360.6K | 15,656 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-12-12 | 2022-12-14 | 600 | — | $0 | 78,900 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-12-12 | 2022-12-14 | 600 | $23.03 | $13.8K | 600 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-12-12 | 2022-12-14 | 600 | $28.05 | $16.8K | 0 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise deriv | 2022-11-15 | 2022-11-16 | 8,125 | — | $0 | 21,875 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | M Exercise | 2022-11-15 | 2022-11-16 | 8,125 | $14.00 | $113.8K | 8,125 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | S Sale | 2022-11-15 | 2022-11-16 | 8,125 | $22.05 | $179.2K | 0 | SEC↗ |
| Fairmount Healthcare Fund GP L | Director, 10% Owner | P Buy | 2022-08-17 | 2022-08-19 | 425,531 | $23.50 | $10.00M | 1,363,764 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Moses Jennifer K. | Director | A Award deriv | 2022-06-08 | 2022-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-06-01 | 2022-06-02 | 30,000 | $12.20 | $366.0K | 480,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-05-02 | 2022-05-04 | 30,000 | $13.04 | $391.2K | 510,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-04-04 | 2022-04-05 | 3,600 | $18.93 | $68.1K | 540,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-04-01 | 2022-04-05 | 26,400 | $18.92 | $499.5K | 544,505 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-03-02 | 2022-03-03 | 11,106 | $17.36 | $192.8K | 570,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-03-01 | 2022-03-03 | 18,894 | $17.82 | $336.7K | 582,011 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-02-03 | 2022-02-03 | 909 | $19.16 | $17.4K | 600,905 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | A Award deriv | 2022-02-02 | 2022-02-03 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Meisner Lara | General Counsel and Secretar | A Award deriv | 2022-02-02 | 2022-02-03 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Katz Barrett | Chief Medical Officer | A Award deriv | 2022-02-02 | 2022-02-03 | 110,000 | — | $0 | 110,000 | SEC↗ |
| Humer Kristian | CFO and CBO | A Award deriv | 2022-02-02 | 2022-02-03 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-02-02 | 2022-02-03 | 12,340 | $18.47 | $227.9K | 601,814 | SEC↗ |
| Violin Jonathan | Chief Executive Officer | S Sale | 2022-02-01 | 2022-02-03 | 16,751 | $19.55 | $327.5K | 614,154 | SEC↗ |
| Humer Kristian | CFO and CBO | A Award deriv | 2021-12-31 | 2022-01-03 | 121,371 | — | $0 | 121,371 | SEC↗ |
| Violin Jonathan | See Remarks | C Conversion deriv | 2021-12-08 | 2021-12-10 | 9,413 | — | $0 | 0 | SEC↗ |
| Violin Jonathan | See Remarks | C Conversion | 2021-12-08 | 2021-12-10 | 627,564 | — | $0 | 630,905 | SEC↗ |
| Frazier Life Sciences Public F | 10% Owner | P Buy | 2021-09-23 | 2021-09-28 | 200,000 | $11.00 | $2.20M | 1,505,200 | SEC↗ |
| Fairmount Healthcare Fund L.P. | Director | P Buy | 2021-09-21 | 2021-09-23 | 909,000 | $11.00 | $10.00M | 938,233 | SEC↗ |
| Humer Kristian | CFO and CBO | A Award deriv | 2021-07-26 | 2021-07-27 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Moses Jennifer K. | Director | A Award deriv | 2021-07-14 | 2021-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2021-06-03 | 2021-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2021-06-03 | 2021-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2021-06-03 | 2021-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Morris Arlene | Director | A Award deriv | 2021-02-04 | 2021-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2021-02-04 | 2021-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2021-02-04 | 2021-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hatfield Jeffrey S. | Director | A Award deriv | 2021-02-04 | 2021-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TURNER JOSEPH L | Director | A Award deriv | 2021-02-04 | 2021-02-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Violin Jonathan | CEO and President | A Award deriv | 2021-01-18 | 2021-01-20 | 800,075 | — | $0 | 800,075 | SEC↗ |
| Leverone Jason A. | Chief Financial Officer | A Award deriv | 2021-01-18 | 2021-01-20 | 311,785 | — | $0 | 311,785 | SEC↗ |
| Katz Barrett | Chief Medical Officer | A Award deriv | 2021-01-18 | 2021-01-21 | 356,000 | — | $0 | 356,000 | SEC↗ |